TITLE

myeloproliferative disorder

PUB. DATE
January 2009
SOURCE
Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1525
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
A reference entry for "myeloproliferative disorder" which refers to several hematologic malignancies is presented.
ACCESSION #
62152562

 

Related Articles

  • myelofibrosis. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p527 

    An encyclopedia entry for "myelofibrosis" is presented. Myelofibrosis is an alternative term for myelosclerosis.

  • myelosclerosis. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p527 

    An encyclopedia entry for "myelosclerosis" is presented. It refers to an increase of fibrous tissue within the bone marrow. The condition may be primary, or with no obvious cause, or secondary, or resulting from another bone marrow disease. The main symptoms of myelosclerosis are those of...

  • myelofibrosis.  // Taber's Cyclopedic Medical Dictionary;2005, p1414 

    A definition of the medical term "myelofibrosis" is presented, which refers to a myeloproliferative disorder marked by the overproduction of a single stem cell clone and reactive bone marrow fibrosis. The definition is from the "Taber's Cyclopedic Medical Dictionary," published by F.A. Davis Co.

  • myeloproliferative disorders. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p527 

    An encyclopedia entry for "myeloproliferative disorders" is presented. It refers to conditions characterized by the abnormal proliferation of one or more blood cell groups within the bone marrow.

  • Transitions Among the Myeloproliferative Disorders. Glasser, Robert M.; Walker, Richard I. // Annals of Internal Medicine;Aug69, Vol. 71 Issue 2, p285 

    Indicates that transitions among the three major disorders included in the myeloproliferative syndrome do not occur. Difficulty of proving the relationship between chronic myelogenous leukemia and myelofibrosis with myeloid metaplasia; Conclusions.

  • The Pathogenesis of Myelofibrosis in Myeloproliferative Disorders. Groopman, Jerome E. // Annals of Internal Medicine;Jun80, Vol. 92 Issue 6, p857 

    Editorial. Comments on the genesis of marrow fibroblast proliferation in myeloproliferative disorders. Conditions that can be associated with marked myelofibrosis; Description of fibroblasts; Evidence provided by similar methods applied to myeloproliferative states; Views on bone marrow...

  • Broad molecular screening of an unclassifiable myeloproliferative disorder reveals an unexpected ETV6/ABL1 fusion transcript. Meyer-Monard, S; Mühlematter, D; Streit, A; Chase, A J; Gratwohl, A; Cross, N C P; Jotterand, M; Tichelli, A // Leukemia (08876924);Jun2005, Vol. 19 Issue 6, p1096 

    Presents a letter to the editor of the journal "Leukemia," describing a case of atypical myeloproliferative disorder with a cryptic ETV6/ABL1 fusion transcript detected by broad molecular screening with a multiplex polymerase chain reaction system.

  • myelosclerosis.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1526 

    A reference entry for the term "myelosclerosis" which refers to the sclerosis of the spinal cord is presented.

  • Serum Vitamin B(sub12) Content and Unsaturated Vitamin B9sub12)--Binding Capacity in Myeloproliferative Disease. Gilbert, Harriet S.; Krauss, Stephen; Pasternack, Bernard; Herbert, Victor; Wasserman, Louis R. // Annals of Internal Medicine;Oct69, Vol. 71 Issue 4, p719 

    Focuses on a study which assessed the elevations in serum B[sub12] and unsaturated vitamin B[sub12]-binding capacity (UBBC) in patients with myeloproliferative disorders. Comparison of the B[sub12] and UBBC levels; Effects of phlebotomy; Correlations between UBBC levels and erythroid activity...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics